Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Plos One
|
December 11, 2012
Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode
Eric Chabrol, Alessandra Nurisso, Antoine Daina, et al.
Analytical Biochemistry
|
November 3, 2019
VHH characterization.Recombinant VHHs: Production, characterization and affinity
Eric Chabrol, Johann Stojko, Alexandre Nicolas, et al.
Biophysical Journal
|
February 5, 2015
Alteration of the langerin oligomerization state affects Birbeck granule formation
Eric Chabrol, Michel Thépaut, Colette Dezutter-Dambuyant, et al.
Protein Science : a Publication of the Protein Society
|
June 12, 2021
Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer
Eric Chabrol, Charline Fagnen, Sophie Landron, et al.
ACS Chemical Biology
|
December 23, 2017
Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition
Vanessa Porkolab, Eric Chabrol, Norbert Varga, et al.
Journal of the American Chemical Society
|
January 31, 2013
Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design
Michel Thépaut, Cinzia Guzzi, Ieva Sutkeviciute, et al.
Journal of the American Chemical Society
|
March 10, 2015
Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments
Juan C Muñoz-García, Eric Chabrol, Romain R Vivès, et al.
Organic & Biomolecular Chemistry
|
July 8, 2011
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin
Manuel Andreini, Daniela Doknic, Ieva Sutkeviciute, et al.
AIDS (London, England)
|
November 3, 2011
A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models
Angela Berzi, José J Reina, Roberta Ottria, et al.
Protein Science : a Publication of the Protein Society
|
August 20, 2019
VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH
Lucie Hartmann, Thomas Botzanowski, Mathieu Galibert, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Plos One
|
December 11, 2012
Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode
Eric Chabrol, Alessandra Nurisso, Antoine Daina, et al.
Analytical Biochemistry
|
November 3, 2019
VHH characterization.Recombinant VHHs: Production, characterization and affinity
Eric Chabrol, Johann Stojko, Alexandre Nicolas, et al.
Biophysical Journal
|
February 5, 2015
Alteration of the langerin oligomerization state affects Birbeck granule formation
Eric Chabrol, Michel Thépaut, Colette Dezutter-Dambuyant, et al.
Protein Science : a Publication of the Protein Society
|
June 12, 2021
Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer
Eric Chabrol, Charline Fagnen, Sophie Landron, et al.
ACS Chemical Biology
|
December 23, 2017
Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition
Vanessa Porkolab, Eric Chabrol, Norbert Varga, et al.
Journal of the American Chemical Society
|
January 31, 2013
Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design
Michel Thépaut, Cinzia Guzzi, Ieva Sutkeviciute, et al.
Journal of the American Chemical Society
|
March 10, 2015
Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments
Juan C Muñoz-García, Eric Chabrol, Romain R Vivès, et al.
Organic & Biomolecular Chemistry
|
July 8, 2011
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin
Manuel Andreini, Daniela Doknic, Ieva Sutkeviciute, et al.
AIDS (London, England)
|
November 3, 2011
A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models
Angela Berzi, José J Reina, Roberta Ottria, et al.
Protein Science : a Publication of the Protein Society
|
August 20, 2019
VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH
Lucie Hartmann, Thomas Botzanowski, Mathieu Galibert, et al.
Page
of 2